Aclaris Therapeutics Inc. (NASDAQ: ACRS) said positive interim data from its first-in-human study of ATI-052 are accelerating ...
Zacks Investment Research on MSNOpinion
5 small drug stocks to buy as industry recovery picks up
After a sluggish first half, the drug and biotech sector has staged a recovery over the past two to three months. This ...
Jiangsu Simcere Pharmaceutical Co. Ltd. has identified antibody-drug conjugates (ADCs) comprising antibody or antigen-binding fragments linked to a cytotoxic drug through a linker reported to be ...
Acquisition adds complementary asset to the Pelthos commercial portfolioXeglyze is a novel, FDA-approved prescription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback